About this trial
The purpose of this study is to develop and test CarePair, a mobile application-based needs assessment and service referral platform for family caregivers of persons with dementia designed to alleviate stress and promote psychosocial well being.
The main aims of this study are:
* To evaluate the feasibility and acceptability of the CarePair mobile application. * To explore the potential for CarePair to reduce feelings of depression and burden, and improve caregivers' feelings of self-efficacy.
Caregiver participants will be asked to log in and use the CarePair application and complete study activities for a six-week duration. Researchers will compare the intervention group to an attention control comparator to see if application use is associated with improved psychosocial outcomes at follow-up.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Currently a primary caregiver of a community-dwelling PwD
Provides at least 10 hours of care per week
≥18 years of age
Fluent in English
Disqualifiers
None
Trial design
Parallel
Treatments tested in this trial
CarePair
BehavioralThis study will pilot test the feasibility and acceptability of a digital self-assessment and referral tool using machine learning models to enhance service use and address unmet needs in ADRD caregivers.
Treatment groups
Trial outcomes
Primary outcomes
The Feasibility of the CarePair study as measured by the proportion of family caregivers who complete the study screening survey.
The feasibility of the CarePair study will be measured by the proportion of family caregivers who complete the study screening survey among those who were directly invited to participate the study.
The Feasibility of the CarePair study as measured by the proportion of family caregivers who consent to participate and are enrolled.
The feasibility of the CarePair study will be measured by the proportion of family caregivers who consent to participate among those who were screened into the study. Participants who consent to participate are then immediately randomized to their assigned condition and thus enrolled.
The Feasibility of the CarePair study as measured by the proportion of are deemed eligible based on screening criteria.
The feasibility of the CarePair study will be measured by the proportion of family caregivers who are deemed eligible to participate based on screening criteria among those who completed the study's screening survey.
The Feasibility of the CarePair study as measured by recruitment rates and the proportion of family caregivers that decline participation.
The feasibility of the CarePair study will be measured by the proportion of eligible family caregivers who decline to participate among those who were screened into the study.
Secondary outcomes
Change from Baseline Caregiver Needs scores on a 12-item Needs Assessment
A 12-item caregiver needs assessment will be used to measure family caregivers' care-related needs, such as legal guidance, social support, and education. Total scores range from 12-48, with higher scores representing greater caregiver needs.
Change from Baseline Caregiving Self-Efficacy scores on the 15-item Revised Scale for Caregiving Self-Efficacy
Caregiving Self-Efficacy will be measured using the Revised Scale for Caregiving Self-Efficacy. Total scores range from 0-100, with higher scores indicative of greater feelings of perceived self-efficacy.
Change from Baseline Caregiver Depressive Symptoms as measured by the Patient Health Questionnaire-9 (PHQ-9).
The PHQ-9 will be used to measure family caregiver depressive symptoms. Total scores range from 0-27, with higher scores indicative of greater caregiver depressive symptoms.
Change from Baseline Anxiety scores on the Generalized Anxiety Disorder-7 (GAD-7)
Change in caregivers' anxiety scores will be assessed using the GAD-7. Scores range from 0-21, with higher scores indicating a greater level of anxiety.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
University of Southern California
Lead sponsor
National Institute on Aging (NIA)
Collaborator